Common Misconceptions in General Practice: Unpacking Assumptions About Cancer Screening for Lumps & Bumps

Cutaneous and subcutaneous masses are among the most common reasons patients are presented in canine general practice, yet how these masses are evaluated varies widely from clinic to clinic. For some, fine-needle aspiration (FNA) is performed on as many lumps as possible. For others, the reality of daily practice means FNA is avoided. This real-world complexity has necessitated a change in first-step cancer screening diagnostics to help practitioners better detect cancer. In addition, new innovations in cancer screening like heat diffusion imaging have raised a lot of questions—and been met with skepticism from veterinary teams—about where they fit alongside existing tools like cytology and histopathology and in everyday decision-making.  

In this interactive session, Dr. Natalie Marks and Dr. Liron Levy-Hirsch will review the questions and misconceptions that come up most when discussing mass screening and offer live polling throughout the presentation so attendees can weigh in on how they approach these cases in their own practices. Attendees will leave with a clearer, evidence-based picture of where the testing gap comes from and how clinicians can position themselves to catch cancer earlier.

Not looking for CE credit for this course? You can skip entering your information below and proceed to viewing the webinar here.